<DOC>
	<DOCNO>NCT02465320</DOCNO>
	<brief_summary>The purpose study determine COL-1077 ( 10 % lidocaine vaginal bioadhesive gel ) effective acute-use anesthetic decrease pain intensity associate gynecologic procedure use endometrial biopsy representative procedure .</brief_summary>
	<brief_title>COL-1077 ( Lidocaine Bioadhesive Gel , 10 % ) Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy</brief_title>
	<detailed_description>COL-1077 self-administered patient prior outpatient transvaginal pipelle-directed endometrial biopsy tenaculum placement otherwise healthy woman require biopsy .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<criteria>1 . Female intact uterus , ≥ 40 ≤ 75 year age 2 . For woman think postmenopausal , postmenopausal define least 6 month confirm amenorrhea follicle stimulate hormone ( FSH ) level ≥ 40.0 mIU/mL 3 . Scheduled undergo plan pipelledirected endometrial biopsy tenaculum placement 4 . Able intravaginally selfadminister study drug use supply drug applicator plunger ( eg , adequate manual dexterity ) 5 . Willing able attend study visit complete pain assessment 6 . Willing abstain sexual intercourse 24 hour prior completion endometrial biopsy 24 hour follow endometrial biopsy 7 . Women childbearing potential must use adequate birth control measure course study least 7 day complete study treatment . 8 . Read , understood , provide write informed consent Health Insurance Portability Accountability Act ( HIPAA ) authorization 1 . Pelvic inflammatory disease ( PID ) within past 3 month Screening Visit ( Visit 1 ) ongoing vaginal infection require intravaginal treatment 2 . Coagulation disorder 3 . Experiencing daily baseline pelvic chronic pain 4 . Experiencing menstruation anticipate menstrual cycle study period 5 . Currently use intrauterine device ( IUD ) vaginal ring 6 . Has active vaginal , vulvar cervical lesion , cervical uterine carcinoma 7 . Women pregnant lactating . 8 . Known history hypersensitivity , allergy intolerance lidocaine amino amidetype local anesthetic 9 . Known allergy intolerance aspirin nonsteroidal antiinflammatories 10 . Participation investigational drug device trial within 30 day prior Screening Visit ( Visit 1 ) 11 . Regular use concomitant medication might confound efficacy and/or safety assessment 12 . Chronic pain condition require regular ( eg , daily ) use analgesic and/or antiinflammatory medication 13 . Use Class 1 antiarrhythmic history clinically significant cardiac arrhythmia determine investigator 14 . History severe acute chronic medical psychiatric condition laboratory abnormality could increase risk associate trial participation trial drug administration could interfere interpretation trial result 15 . Evidence current alcohol drug abuse .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>